Arrakis Therapeutics is building a proprietary platform that re-architects drug discovery for RNA targets and to build a pipeline of rSMs to treat a range of diseases, including neurology, oncology and rare genetic diseases.

Arrakis’s platform integrates leading-edge RNA bioinformatics and structural tools, RNA-specific chemical and biological assays and traditional medicinal chemistry to identify tractable RNA targets, design drug molecules, and select candidates for clinical development.

(click to enlarge)

Back to Top